A randomized controlled trial tested a model using donor-derived cell-free DNA for predicting graft rejection.

(HealthDay News) — Having a supratherapeutic international normalized ratio (INR) while taking warfarin does not significantly increase the risk for brain bleeding after blunt head trauma in older ...

About 1 in 6 patients with GG1 prostate cancer have a higher risk of prostate cancer-specific death, data suggest.

(HealthDay News) — Patients undergoing major surgery who experience alcohol withdrawal syndrome (AWS) and delirium tremens (DT) face significantly higher risks for complications, according to a study ...

Less than one-quarter of next-in-class cancer drugs demonstrated a survival benefit over existing in-class agents in head-to-head trials.

(HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) recommends screening adults for unhealthy alcohol use and providing brief behavioral counseling interventions for those engaged in ...

Confirmatory trials for cancer drugs that move from accelerated approval to regular approval often fail to demonstrate evidence of OS or QOL benefits.

Inverse associations seen between higher adherence to three diets with annual rate of total chronic disease accumulation.